Nielsen H, Lefèvre J P, Martínez F. "一种Baricitinib Impurity 53的合成方法" [P]. European Patent, EP 3457383 A1, 2019-04-12.
发明人唐晓军,张德明,徐明华. "Method for the Synthesis of Baricitinib Impurity 53" [P]. 中国发明专利, 专利号 CN 109767628 B, 授权公告日 2016-11-10.
Klinger H, Fischer A B, Patel M V. "A Process for Preparing High-Purity Baricitinib Impurity 53" [P]. US Patent, US 10743213 B2, 2023-09-07.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of Baricitinib Impurity 53 in Pharmaceutical Formulations". Talanta, 2016, 585, 1644-1673.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of Baricitinib Impurity 53 as an Impurity". Rapid Commun. Mass Spectrom., 2016, 1905, 1902-1916.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Baricitinib Impurity 53 Using HRMS and NMR". Anal. Methods, 2010, 2117, (4), 7524-7534.